Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Daily volatility informs risk tolerance and timing decisions. This overview highlights why investors should monitor volatility and adjust strategies.
28,131 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
As Madrigal prepares to report its 2025 earnings, investors weigh pipeline progress, cash runway, and milestones ahea...
A public signaling push sets an August deadline for Bitcoin’s BIP-110 fork fight, forcing exchanges and miners to pla...
AbbVie’s latest results reveal more than a quarterly beat. This article breaks down the growth engines behind the imp...
Beyond shakes up its identity, dropping meat from its name to chase a broader plant protein future as plant-based sal...
Imagine owning stocks that pay you reliably for decades. This guide shows how to find the best dividend stocks hold a...
AI-driven signals suggest XRP could break out to $1.40-$1.55 in the next 15 days, depending on clearing a key resista...
Bitcoin failed to clear a key ceiling near $63,000 as a high-flying altcoin, BEAT, gapped higher by about 40%. Trader...
CryptoQuant data shows the altcoin market reaches extreme weakness, with 40% of tokens trading near all-time lows as ...
A federal judge paused the $81 billion Paramount-Warner merger for two weeks as 12 states challenge the deal over com...
Bitcoin miners face mounting strain as key metrics show bitcoin miners under pressure amid softer prices, signaling s...
AMD investors face a bumpy road as market reality clashes with AI optimism. This guide explains what unfortunate news...